Ephrin-B1/2 (phospho Tyr329) Polyclonal Antibody

Rabbit Anti-Ephrin-B1/2 (phospho Tyr329) Polyclonal Antibody

Product Specifications

Background

The ephrin B1 encoded by EFNB2 is a type I membrane protein and a ligand of Eph-related receptor tyrosine kinases. It may play a role in cell adhesion and function in the development or maintenance of the nervous system.

CAS Number

9007-83-4

Product Name Alternative

EFNB1; EFL3; EPLG2; LERK2; Ephrin-B1; EFL-3; ELK ligand; ELK-L; EPH-related receptor tyrosine kinase ligand 2; LERK-2; EFNB2; EPLG5; HTKL; LERK5; Ephrin-B2; EPH-related receptor tyrosine kinase ligand 5; LERK-5; HTK ligand; HTK-L

Gene ID

1947/1948

Accession Number

P98172/P52799

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from human Ephrin-B1/2 around the phosphorylation site of Y329

Clonality

Polyclonal

Tag

Ephrin-B1

Applications

IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

Phospho-Ephrin-B1/2 (Y329) Polyclonal Antibody detects endogenous levels of Ephrin-B1/2 protein only when phosphorylated at Y329.

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300; ELISA 1:10000; IF 1:50-200